Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Final Agenda for CHI’s 3rd Annual X-Gen Congress & ExpoNavigating the Future of Genomic Technologies. March 5-8, 2012 at the Hilton San Diego Resort
• Extraordinary output of genomic data • Therapeutic interventions as well as diagnostic and prognostic tools for disease • Genetic diversity and genomic variation • Biological insights into the “active genome” • Linking mutations to human diseases • Understanding how host-microbes interactions impact health and disease • Data storage, transfer, and management • Efficient workflow strategies Discover why technology and data are the driving forces that enable genomic discoveries as you design a program based on your unique research needs. For more information, please visit http://www.xgencongress.com/ Clinical Genomics Tracks (Concurrent Programs Running March 5-7) Fourth Annual Epigentics Exploring Effects * Environment * Expression Fourth Annual Quantitative PCR Discovery. . .Data. . .Diseases. . .Diagnostics Targeting Non-Coding RNA The Long and the Short of It Genomic Data Analysis and Interpretation Turning Data into Knowledge Next-Gen Sequencing Tracks (Concurrent Programs Running March 7-8) RNA-Seq Insights into the Active Genome DNA-Seq Microbes to Man and Back Again Successful Sequencing Projects…Pipelines… Sequencing Data Storage and Management IT Infrastructures to Support Data Intensive Science To view the full agendas, please visit http://www.xgencongress.com/ Plenary Keynotes: "Recent Advances in Cancer Genome Sequencing" Richard K. Wilson, Ph.D., Professor of Genetics & Director, The Genome Institute, Washington University School of Medicine "Making a Definitive Diagnosis: Successful Clinical Application of Diagnostic Whole Genome Sequencing" Samuel Levy, Ph.D., Director of Genomic Sciences, Scripps Translational Science Institute and ScrippsGenomic Medicine, Professor of Molecular and Experimental Medicine, The Scripps Research Institute "Can Genomes Improve Medical Outcomes?" Elizabeth A. Worthey, Ph.D., Assistant Professor, The Human and Molecular Genetics Center, Pediatrics, Bioinformatics, Medical College of Wisconsin About Cambridge Healthtech Institute Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine. Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. www.chicorporate.com For more information: Tracey Fielding Cambridge Healthtech Institute (781) 972-5429 tfielding@healthtech.com # # # Since 1992, Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|